Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker - Furuhashi, Masato; Moniwa, Norihito; Mita, Tomohiro; Fuseya, Takahiro; Ishimura, Shutaro; Ohno, Kohei; Shibata, Satoru; Tanaka, Marenao; Watanabe, Yuki; Akasaka, Hiroshi; Ohnishi, Hirofumi; Yoshida, Hideaki; et al. (American journal of hypertension, 2015)
Keywords: Aged; Angiotensin II Type 1 Receptor Blockers - therapeutic use; Antihypertensive Agents - therapeutic use; Biomarkers - urine; Blood Pressure - drug effects; Case-Control Studies; Female; Humans; Hypertension - drug therapy; Hypertension - enzymology; Hypertension - physiopathology; Hypertension - urine; Imidazoles - therapeutic use; Japan; Kidney - drug effects; Kidney - enzymology; Kidney - physiopathology; Male; Middle Aged; Multivariate Analysis; Peptidyl-Dipeptidase A - urine; Tetrazoles - therapeutic use; Time Factors; Treatment Outcome; Up-Regulation; Japan; blood pressure; olmesartan; urinary protein; urine; angiotensin II receptor blocker; angiotensin-converting enzyme 2; hypertension